Sungyoung Lee - Concepedia

Author

Sungyoung Lee

Also Known As

Byeong-Soo Jeong, Lee, Sungyoung, SUNGYOUNG LEE, Selyeong Lee, Sung Young Lee, Sung-Young Lee, SungYoung Lee, Sungyoung Lee, You Sun Kim

271

Publications

4.6K

Citations

H-Index

169

Concepts

All Affiliations

Seoul National University Hormel (United States)University of Minnesota Seoul National University Hospital Kyung Hee University

About

Sungyoung Lee is an author at Seoul National University specializing in medicine, cell biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	36	1.8K
2	Engineering	12	13	243
3	Health Sciences	7	7	373
4	Natural Sciences	4	4	110
5	Management	1	1	20

Sungyoung Lee

101

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study Byong Duk Ye, Marina Pesegova, Olga Alexeeva, The Lancet Biosimilar Ct-p13Originator InfliximabGastroenterologyClinical GastroenterologyUlcerative Colitis	2019	203
Associations of <i>ABCB1, ABCC2</i>, and <i>ABCG2</i> polymorphisms with irinotecan‐pharmacokinetics and clinical outcome in patients with advanced non‐small cell lung cancer Ji‐Youn Han, Hyeong‐Seok Lim, Yeon‐Kyeong Yoo, Cancer	2007	196
A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study Dae‐Hyun Yoo, Artur Racewicz, Jan Brzezicki, Arthritis Research & Therapy	2016	170
USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer Sanguine Byun, Sungyoung Lee, Ji‐Hoon Lee, Clinical Cancer Research	2013	146
Isoliquiritigenin Induces Apoptosis and Inhibits Xenograft Tumor Growth of Human Lung Cancer Cells by Targeting Both Wild Type and L858R/T790M Mutant EGFR Sung Keun Jung, Mee‐Hyun Lee, Do Young Lim, Journal of Biological Chemistry Tumor BiologyOncogenic AgentMedicineIsoliquiritigenin Induces ApoptosisCell Death	2014	129
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial Justin Stebbing, Y. Baranau, Valeriy Baryash, The Lancet Oncology Breast OncologyHealth SciencesMedicineClinical TrialsBreast Cancer	2017	119
Curcumin Suppresses Proliferation of Colon Cancer Cells by Targeting CDK2 Tae‐Gyu Lim, Sungyoung Lee, Zunnan Huang, Cancer Prevention Research Chemoprevention StrategyPathologyCancer BiologyTumor BiologyOncology	2014	116
Novel TOPK Inhibitor HI-TOPK-032 Effectively Suppresses Colon Cancer Growth Dong Joon Kim, Yan Li, Kanamata Reddy, Cancer Research Chemoprevention StrategyGastrointestinal OncologyMedicineTumor GrowthReceptor Tyrosine Kinase	2012	112
Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer Ji‐Youn Han, Hyeong‐Seok Lim, Yong Hoon Park, Lung Cancer OncologyMedicineIrinotecan PharmacokineticsBronchial NeoplasmAnti-cancer Agent	2008	103
[6]-Shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2 Myoung Ok Kim, Mee‐Hyun Lee, Naomi Oi, Carcinogenesis	2013	98

Page 1